arginyl-glycyl-aspartic acid has been researched along with mannose-6-phosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dumler, I; Haller, H; Kiyan, J; Kiyan, R; Shushakova, N; Tkachuk, N; Tkachuk, S | 1 |
Fretz, MM; Kok, RJ; Temming, K | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and mannose-6-phosphate
Article | Year |
---|---|
Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs.
Topics: Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Mannosephosphates; Oligopeptides; Organoplatinum Compounds; Platinum Compounds; Polyethylene Glycols; Protein Kinase Inhibitors; Signal Transduction | 2008 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and mannose-6-phosphate
Article | Year |
---|---|
Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Topics: Apoptosis; bcl-Associated Death Protein; Biological Transport; Blotting, Western; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Glucose; Humans; Immunoprecipitation; In Situ Nick-End Labeling; Mannosephosphates; Mesangial Cells; Microscopy, Confocal; Microscopy, Fluorescence; Nuclear Envelope; Oligopeptides; Oncogene Protein v-akt; Receptors, Urokinase Plasminogen Activator; Signal Transduction; Urokinase-Type Plasminogen Activator | 2008 |